USD 71.47
(-1.09%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | 2.53 Billion USD | -5.68% |
2023 | 2.81 Billion USD | -0.18% |
2022 | 2.82 Billion USD | -6.67% |
2021 | 3.02 Billion USD | -0.45% |
2020 | 3.03 Billion USD | -0.53% |
2019 | 3.05 Billion USD | -7.54% |
2018 | 3.3 Billion USD | -0.56% |
2017 | 3.32 Billion USD | -0.67% |
2016 | 3.34 Billion USD | -8.09% |
2015 | 3.63 Billion USD | -14.71% |
2014 | 4.26 Billion USD | -11.2% |
2013 | 4.8 Billion USD | -4.56% |
2012 | 5.03 Billion USD | 238.28% |
2011 | 1.48 Billion USD | 2.77% |
2010 | 1.44 Billion USD | -23.9% |
2009 | 1.9 Billion USD | -13.52% |
2008 | 2.2 Billion USD | 19552.65% |
2007 | 11.19 Million USD | -82.52% |
2006 | 64.08 Million USD | 0.0% |
2005 | - USD | -100.0% |
2004 | 947 Thousand USD | -53.35% |
2003 | 2.03 Million USD | -26.13% |
2002 | 2.74 Million USD | -91.11% |
2001 | 30.89 Million USD | 21.71% |
2000 | 25.38 Million USD | 2208.0% |
1999 | 1.1 Million USD | -71.05% |
1998 | 3.8 Million USD | 3700.0% |
1997 | 100 Thousand USD | -96.0% |
1996 | 2.5 Million USD | 19.05% |
1995 | 2.1 Million USD | -12.5% |
1994 | 2.4 Million USD | 0.0% |
1993 | - USD | 0.0% |
1992 | - USD | 0.0% |
1991 | - USD | 0.0% |
1990 | - USD | -100.0% |
1989 | 1 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q3 | 2.55 Billion USD | -0.36% |
2024 Q4 | 2.53 Billion USD | -0.96% |
2024 Q2 | 2.56 Billion USD | -0.37% |
2024 Q1 | 2.57 Billion USD | -8.52% |
2023 Q3 | 2.82 Billion USD | -0.1% |
2023 Q2 | 2.82 Billion USD | -0.1% |
2023 Q1 | 2.82 Billion USD | -3.24% |
2023 FY | 2.81 Billion USD | -0.18% |
2023 Q4 | 2.81 Billion USD | -0.1% |
2022 FY | 2.82 Billion USD | -6.67% |
2022 Q3 | 2.84 Billion USD | -8.04% |
2022 Q4 | 2.92 Billion USD | 2.71% |
2022 Q2 | 3.09 Billion USD | 0.01% |
2022 Q1 | 3.09 Billion USD | 2.24% |
2021 Q1 | 2.78 Billion USD | -8.41% |
2021 Q2 | 2.77 Billion USD | -0.34% |
2021 Q4 | 3.02 Billion USD | -3.7% |
2021 Q3 | 3.14 Billion USD | 13.26% |
2021 FY | 3.02 Billion USD | -0.45% |
2020 Q1 | 3.09 Billion USD | 1.22% |
2020 Q2 | 3.57 Billion USD | 15.63% |
2020 Q3 | 3.31 Billion USD | -7.25% |
2020 Q4 | 3.03 Billion USD | -8.37% |
2020 FY | 3.03 Billion USD | -0.53% |
2019 Q4 | 3.05 Billion USD | -0.65% |
2019 FY | 3.05 Billion USD | -7.54% |
2019 Q2 | 3.13 Billion USD | -0.55% |
2019 Q1 | 3.14 Billion USD | -4.68% |
2019 Q3 | 3.07 Billion USD | -1.83% |
2018 FY | 3.3 Billion USD | -0.56% |
2018 Q2 | 3.37 Billion USD | 0.61% |
2018 Q4 | 3.3 Billion USD | 1.04% |
2018 Q3 | 3.27 Billion USD | -3.08% |
2018 Q1 | 3.35 Billion USD | 0.93% |
2017 Q4 | 3.32 Billion USD | 2.38% |
2017 FY | 3.32 Billion USD | -0.67% |
2017 Q1 | 3.32 Billion USD | -0.67% |
2017 Q2 | 3.3 Billion USD | -0.44% |
2017 Q3 | 3.24 Billion USD | -1.9% |
2016 Q4 | 3.34 Billion USD | -2.24% |
2016 Q3 | 3.42 Billion USD | 0.48% |
2016 Q2 | 3.4 Billion USD | -6.24% |
2016 Q1 | 3.63 Billion USD | -0.2% |
2016 FY | 3.34 Billion USD | -8.09% |
2015 Q4 | 3.63 Billion USD | -7.67% |
2015 FY | 3.63 Billion USD | -14.71% |
2015 Q2 | 3.93 Billion USD | -0.38% |
2015 Q3 | 3.94 Billion USD | 0.06% |
2015 Q1 | 3.95 Billion USD | -7.33% |
2014 Q1 | 4.3 Billion USD | -11.11% |
2014 Q2 | 4.27 Billion USD | -0.66% |
2014 Q3 | 4.27 Billion USD | -0.07% |
2014 FY | 4.26 Billion USD | -11.2% |
2014 Q4 | 4.26 Billion USD | -0.07% |
2013 Q3 | 5 Billion USD | -0.0% |
2013 Q1 | 5.03 Billion USD | 0.01% |
2013 Q2 | 5 Billion USD | -0.62% |
2013 Q4 | 4.83 Billion USD | -3.3% |
2013 FY | 4.8 Billion USD | -4.56% |
2012 Q4 | 5.03 Billion USD | 226.53% |
2012 FY | 5.03 Billion USD | 238.28% |
2012 Q3 | 1.54 Billion USD | 0.99% |
2012 Q2 | 1.52 Billion USD | 1.29% |
2012 Q1 | 1.5 Billion USD | 1.27% |
2011 Q2 | 1.45 Billion USD | 1.21% |
2011 Q1 | 1.43 Billion USD | -0.92% |
2011 Q3 | 1.47 Billion USD | 1.23% |
2011 FY | 1.48 Billion USD | 2.77% |
2011 Q4 | 1.48 Billion USD | 1.23% |
2010 Q1 | 1.51 Billion USD | -20.48% |
2010 Q2 | 1.45 Billion USD | -3.62% |
2010 Q3 | 1.43 Billion USD | -1.97% |
2010 Q4 | 1.44 Billion USD | 1.29% |
2010 FY | 1.44 Billion USD | -23.9% |
2009 Q4 | 1.9 Billion USD | -5.15% |
2009 FY | 1.9 Billion USD | -13.52% |
2009 Q2 | 2.11 Billion USD | -2.6% |
2009 Q1 | 2.17 Billion USD | -1.35% |
2009 Q3 | 2 Billion USD | -5.11% |
2008 Q4 | 2.2 Billion USD | 26.69% |
2008 FY | 2.2 Billion USD | 19552.65% |
2008 Q3 | 1.73 Billion USD | -4.92% |
2008 Q1 | 2.03 Billion USD | 18085.45% |
2008 Q2 | 1.82 Billion USD | -10.28% |
2007 Q2 | 8.85 Million USD | -81.22% |
2007 Q3 | 9.6 Million USD | 8.45% |
2007 FY | 11.19 Million USD | -82.52% |
2007 Q4 | 11.19 Million USD | 16.66% |
2007 Q1 | 47.13 Million USD | -26.45% |
2006 Q2 | - USD | 0.0% |
2006 Q3 | 57.77 Million USD | 0.0% |
2006 FY | 64.08 Million USD | 0.0% |
2006 Q4 | 64.08 Million USD | 10.93% |
2006 Q1 | - USD | 0.0% |
2005 Q3 | 590 Thousand USD | -16.67% |
2005 FY | - USD | -100.0% |
2005 Q4 | - USD | -100.0% |
2005 Q1 | 827 Thousand USD | -12.67% |
2005 Q2 | 708 Thousand USD | -14.39% |
2004 Q1 | 1.85 Million USD | -8.67% |
2004 FY | 947 Thousand USD | -53.35% |
2004 Q4 | 947 Thousand USD | -38.23% |
2004 Q3 | 1.53 Million USD | -9.29% |
2004 Q2 | 1.69 Million USD | -8.85% |
2003 Q3 | 2.09 Million USD | -9.23% |
2003 Q2 | 2.3 Million USD | -8.45% |
2003 Q1 | 2.52 Million USD | -8.3% |
2003 Q4 | 2.03 Million USD | -3.06% |
2003 FY | 2.03 Million USD | -26.13% |
2002 Q1 | 29.61 Million USD | -4.16% |
2002 Q4 | 2.74 Million USD | -90.19% |
2002 Q3 | 28.01 Million USD | -1.83% |
2002 FY | 2.74 Million USD | -91.11% |
2002 Q2 | 28.53 Million USD | -3.64% |
2001 Q2 | 26.59 Million USD | -0.14% |
2001 FY | 30.89 Million USD | 21.71% |
2001 Q4 | 30.89 Million USD | 9.8% |
2001 Q3 | 28.14 Million USD | 5.83% |
2001 Q1 | 26.63 Million USD | 4.89% |
2000 Q2 | 412 Thousand USD | 3.0% |
2000 Q4 | 25.38 Million USD | 6077.13% |
2000 FY | 25.38 Million USD | 2208.0% |
2000 Q1 | 400 Thousand USD | -63.64% |
2000 Q3 | 411 Thousand USD | -0.24% |
1999 Q3 | 1.1 Million USD | -26.67% |
1999 FY | 1.1 Million USD | -71.05% |
1999 Q4 | 1.1 Million USD | 0.0% |
1999 Q2 | 1.5 Million USD | -46.43% |
1999 Q1 | 2.8 Million USD | -26.32% |
1998 Q4 | 3.8 Million USD | 171.43% |
1998 Q3 | 1.4 Million USD | 75.0% |
1998 Q1 | - USD | -100.0% |
1998 FY | 3.8 Million USD | 3700.0% |
1998 Q2 | 800 Thousand USD | 0.0% |
1997 Q3 | - USD | 0.0% |
1997 Q4 | 100 Thousand USD | 0.0% |
1997 FY | 100 Thousand USD | -96.0% |
1997 Q1 | 2.7 Million USD | 8.0% |
1997 Q2 | - USD | -100.0% |
1996 FY | 2.5 Million USD | 19.05% |
1996 Q4 | 2.5 Million USD | 4.17% |
1996 Q3 | 2.4 Million USD | 9.09% |
1996 Q2 | 2.2 Million USD | 4.76% |
1996 Q1 | 2.1 Million USD | 0.0% |
1995 Q3 | 3 Million USD | 20.0% |
1995 FY | 2.1 Million USD | -12.5% |
1995 Q1 | 2.2 Million USD | -8.33% |
1995 Q4 | 2.1 Million USD | -30.0% |
1995 Q2 | 2.5 Million USD | 13.64% |
1994 Q3 | 1.5 Million USD | 0.0% |
1994 FY | 2.4 Million USD | 0.0% |
1994 Q2 | - USD | 0.0% |
1994 Q1 | - USD | 0.0% |
1994 Q4 | 2.4 Million USD | 60.0% |
1993 FY | - USD | 0.0% |
1993 Q2 | - USD | 0.0% |
1993 Q3 | - USD | 0.0% |
1993 Q4 | - USD | 0.0% |
1992 Q1 | - USD | 0.0% |
1992 Q2 | - USD | 0.0% |
1992 FY | - USD | 0.0% |
1992 Q4 | - USD | 0.0% |
1992 Q3 | - USD | 0.0% |
1991 FY | - USD | 0.0% |
1991 Q4 | - USD | 0.0% |
1990 Q4 | - USD | 0.0% |
1990 Q2 | - USD | 0.0% |
1990 FY | - USD | -100.0% |
1989 Q4 | 1 Million USD | 0.0% |
1989 FY | 1 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 85.7 Million USD | -2857.319% |
AngioDynamics, Inc. | 5.91 Million USD | -42757.626% |
AtriCure, Inc. | 74.49 Million USD | -3302.422% |
Avinger, Inc. | 15.39 Million USD | -16363.787% |
Azenta, Inc. | 60.43 Million USD | -4093.858% |
BioLife Solutions, Inc. | 42.69 Million USD | -5837.083% |
The Cooper Companies, Inc. | 2.56 Billion USD | 1.347% |
Daxor Corporation | 755.65 Thousand USD | -335315.842% |
Ekso Bionics Holdings, Inc. | 7.16 Million USD | -35259.933% |
Femasys Inc. | 6.7 Million USD | -37724.871% |
GlucoTrack, Inc. | 196 Thousand USD | -1293063.265% |
Harvard Bioscience, Inc. | 42.77 Million USD | -5825.701% |
ICU Medical, Inc. | 1.7 Billion USD | -48.682% |
Intuitive Surgical, Inc. | 89.8 Million USD | -2722.494% |
KORU Medical Systems, Inc. | 4.44 Million USD | -56919.833% |
LeMaitre Vascular, Inc. | 19.09 Million USD | -13173.632% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 970 Million USD | -161.299% |
Microbot Medical Inc. | 231 Thousand USD | -1097129.437% |
Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -34473.096% |
Merit Medical Systems, Inc. | 891.35 Million USD | -184.352% |
Nephros, Inc. | 1.83 Million USD | -137950.109% |
NovoCure Limited | 596.24 Million USD | -325.096% |
NEXGEL, Inc. | 2.79 Million USD | -90486.133% |
NEXGEL, Inc. | 2.79 Million USD | -90486.133% |
Singular Genomics Systems, Inc. | 75.28 Million USD | -3266.539% |
OraSure Technologies, Inc. | 13.5 Million USD | -18669.254% |
Pro-Dex, Inc. | 13.54 Million USD | -18609.677% |
Pulse Biosciences, Inc. | 9.14 Million USD | -27618.723% |
Predictive Oncology Inc. | 2.85 Million USD | -88621.212% |
Precision Optics Corporation, Inc. | 3.43 Million USD | -73699.062% |
QuidelOrtho Corporation | 2.61 Billion USD | 3.041% |
Repligen Corporation | 711.8 Million USD | -256.081% |
Sanara MedTech Inc. | 11.79 Million USD | -21394.033% |
STAAR Surgical Company | 35.83 Million USD | -6973.171% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 342 Thousand USD | -741011.111% |
DENTSPLY SIRONA Inc. | 2.29 Billion USD | -10.248% |
Jin Medical International Ltd. | 4.11 Million USD | -61524.119% |